| P50 | author | Stuart Morton | Q39186403 |
| | Massimiliano Cadamuro | Q39186439 |
| P2093 | author name string | Carlo Spirli | |
| | Carola M Morell | |
| | Luca Fabris | |
| | Luigi Locatelli | |
| | Mario Strazzabosco | |
| | Romina Fiorotto | |
| P2860 | cites work | Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. | Q39339148 |
| | AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. | Q39719643 |
| | Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase | Q40316727 |
| | Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination | Q40366558 |
| | Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes | Q40844345 |
| | Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib | Q42213282 |
| | Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways | Q42452939 |
| | WNT/β-catenin signaling in polycystic kidney disease. | Q44357753 |
| | Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). | Q46142296 |
| | Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. | Q53563592 |
| | Mechanoregulation of intracellular Ca2+ in human autosomal recessive polycystic kidney disease cyst-lining renal epithelial cells | Q80650134 |
| | The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein | Q24292750 |
| | Wnt/beta-catenin signaling and small molecule inhibitors | Q24597197 |
| | Autosomal dominant polycystic kidney disease: the last 3 years | Q24656249 |
| | A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells | Q28245051 |
| | Cell adhesion: integrating cytoskeletal dynamics and cellular tension | Q29618066 |
| | Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 |
| | Polycystic kidney disease | Q33709685 |
| | Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. | Q34091331 |
| | ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice | Q34399971 |
| | The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). | Q34717186 |
| | Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease | Q35103361 |
| | Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice | Q35269164 |
| | Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. | Q35890950 |
| | c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease | Q36109160 |
| | E-cadherin plays an essential role in collective directional migration of large epithelial sheets | Q36282908 |
| | Fellow travellers: emergent properties of collective cell migration | Q36382073 |
| | Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1. | Q36559697 |
| | The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin | Q36856314 |
| | A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors | Q37128015 |
| | Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice | Q37184171 |
| | Rac1 GTPase: a "Rac" of all trades. | Q37371665 |
| | E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer | Q37372547 |
| | T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease. | Q37429266 |
| | Polycystic liver diseases: congenital disorders of cholangiocyte signaling | Q37868328 |
| | Apico-basal polarity in polycystic kidney disease epithelia | Q37887112 |
| | Regulation of small GTPases at epithelial cell-cell junctions | Q37903873 |
| | The complex world of WNT receptor signalling | Q38059785 |
| | Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling | Q38289224 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | congenital disorder | Q727096 |
| | Congenital hepatic fibrosis | Q1395683 |
| P304 | page(s) | 1713-1723 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis | |
| P478 | volume | 58 | |